ATEC Sees Market Disruption As Long Tail Growth Driver

ATEC reported 1Q24 orthopedic sales of $138.5 million, up 26.9% compared to the first quarter of 2023.

The company said its dominance in lateral spine surgery lays the groundwork for future growth. That position is protected by the competitive moat of ATEC's proprietary neuromonitoring.

Additional growth drivers include the expanding...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us